Dupilumab
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5075 publications
Real world efficacy of dupilumab in switchers versus biological naive CRSwNP patients.
Journal: Rhinology
Published: June 23, 2026
Dupilumab, Asthma, and Lymphoma - Signal or Surveillance Bias?
Journal: African journal of thoracic and critical care medicine
Published: June 22, 2026
In brief: Dupilumab (Dupixent) for allergic fungal rhinosinusitis.
Journal: The Medical letter on drugs and therapeutics
Published: June 15, 2026
Tralokinumab as a cost-saving treatment option for adults and adolescents with moderate-to-severe atopic dermatitis enrolled in US health insurance plans: a budget impact analysis.
Journal: Journal of comparative effectiveness research
Published: June 09, 2026
Alopecia areata during dupilumab therapy: 2 cases and review of the literature.
Journal: JAAD case reports
Published: June 08, 2026
Dupilumab for severe asthma complicated with chronic spontaneous urticaria refractory to omalizumab and mepolizumab: a case report
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: June 03, 2026
Fractional exhaled nitric oxide and nasal nitric oxide as biomarkers in chronic rhinosinusitis.
Journal: Current opinion in allergy and clinical immunology
Published: June 03, 2026
Benefit-risk profile comparison between dupilumab and upadacitinib: a structured benefit-risk assessment of the Heads Up trial.
Journal: The Journal of dermatological treatment
Published: June 01, 2026
Olfactory outcomes after primary endoscopic sinus surgery and dupilumab for postoperative recurrence in eosinophilic chronic rhinosinusitis.
Journal: The Journal of laryngology and otology
Published: June 01, 2026
Last Updated: 06/30/2026